Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Do we have drugs for dementia? No.

× No keyword cloud information.

9 in total

Review 1. Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.

Authors: K Rockwood
Journal: J Neurol Neurosurg Psychiatry Date: 2004-05 Impact factor: 10.154

2. [Statement to the preliminary report of the IQWiG A05-19B ginkgo-containing preparation at Alzheimers dementia].

Authors: Manfred Gogol; Dieter Lüttje; Cornel Sieber; Hansjörg Werner
Journal: Z Gerontol Geriatr Date: 2007-08 Impact factor: 1.281

3. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.

Authors: G K Wilcock; S Lilienfeld; E Gaens
Journal: BMJ Date: 2000-12-09

Review 4. Cholinesterase inhibitors for Alzheimer's disease.

Authors: J Grutzendler; J C Morris
Journal: Drugs Date: 2001 Impact factor: 9.546

5. A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial.

Authors: Jonathan Rubright; Pamela Sankar; David J Casarett; Ruben Gur; Sharon X Xie; Jason Karlawish
Journal: Am J Geriatr Psychiatry Date: 2010-12 Impact factor: 4.105

Review 6. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

Authors: Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson
Journal: CMAJ Date: 2003-09-16 Impact factor: 8.262

7. Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Authors: K Rockwood; J Mintzer; L Truyen; T Wessel; D Wilkinson
Journal: J Neurol Neurosurg Psychiatry Date: 2001-11 Impact factor: 10.154

8. Goal setting and attainment in Alzheimer's disease patients treated with donepezil.

Authors: K Rockwood; J E Graham; S Fay
Journal: J Neurol Neurosurg Psychiatry Date: 2002-11 Impact factor: 10.154

9. Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials.

Authors: Jason Karlawish; Scott Y H Kim; David Knopman; Christopher H van Dyck; Bryan D James; Daniel Marson
Journal: Am J Geriatr Psychiatry Date: 2008-06-12 Impact factor: 4.105

9 in total